These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33783449)

  • 1. [Biomarkers for the diagnosis and management of heart failure: natriuretic peptides].
    Castiglione V; Vergaro G; Aimo A; Prontera C; Musetti V; Masotti S; Battaglia D; Di Cecco P; Emdin M; Passino C
    G Ital Cardiol (Rome); 2021 Apr; 22(4):292-300. PubMed ID: 33783449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for the diagnosis and management of heart failure.
    Castiglione V; Aimo A; Vergaro G; Saccaro L; Passino C; Emdin M
    Heart Fail Rev; 2022 Mar; 27(2):625-643. PubMed ID: 33852110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.
    Maisel AS; Duran JM; Wettersten N
    Heart Fail Clin; 2018 Jan; 14(1):13-25. PubMed ID: 29153197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
    Ibrahim N; Januzzi JL
    Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.
    Tsutsui H; Albert NM; Coats AJS; Anker SD; Bayes-Genis A; Butler J; Chioncel O; Defilippi CR; Drazner MH; Felker GM; Filippatos G; Fiuzat M; Ide T; Januzzi JL; Kinugawa K; Kuwahara K; Matsue Y; Mentz RJ; Metra M; Pandey A; Rosano G; Saito Y; Sakata Y; Sato N; Seferovic PM; Teerlink J; Yamamoto K; Yoshimura M
    J Card Fail; 2023 May; 29(5):787-804. PubMed ID: 37117140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides in heart failure and acute coronary syndrome.
    Gaggin HK; Januzzi JL
    Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond.
    Morfino P; Aimo A; Castiglione V; Vergaro G; Emdin M; Clerico A
    J Cardiovasc Dev Dis; 2022 Aug; 9(8):. PubMed ID: 36005420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updating the role of natriuretic peptide levels in cardiovascular disease.
    Gopal DJ; Iqbal MN; Maisel A
    Postgrad Med; 2011 Nov; 123(6):102-13. PubMed ID: 22104459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.
    Tsutsui H; Albert NM; Coats AJS; Anker SD; Bayes-Genis A; Butler J; Chioncel O; Defilippi CR; Drazner MH; Felker GM; Filippatos G; Fiuzat M; Ide T; Januzzi JL; Kinugawa K; Kuwahara K; Matsue Y; Mentz RJ; Metra M; Pandey A; Rosano G; Saito Y; Sakata Y; Sato N; Seferovic PM; Teerlink J; Yamamoto K; Yoshimura M
    Eur J Heart Fail; 2023 May; 25(5):616-631. PubMed ID: 37098791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
    Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
    Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides: Another tool for the management of cancer?
    Balaguer J; García-Foncillas J; Tuñón J
    Crit Rev Oncol Hematol; 2024 Jan; 193():104219. PubMed ID: 38029944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.
    Mueller C; McDonald K; de Boer RA; Maisel A; Cleland JGF; Kozhuharov N; Coats AJS; Metra M; Mebazaa A; Ruschitzka F; Lainscak M; Filippatos G; Seferovic PM; Meijers WC; Bayes-Genis A; Mueller T; Richards M; Januzzi JL;
    Eur J Heart Fail; 2019 Jun; 21(6):715-731. PubMed ID: 31222929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure.
    Gruson D; Ahn SA; Rousseau MF
    Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].
    Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M
    G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort.
    Geelhoed B; Börschel CS; Niiranen T; Palosaari T; Havulinna AS; Fouodo CJK; Scheinhardt MO; Blankenberg S; Jousilahti P; Kuulasmaa K; Zeller T; Salomaa V; Schnabel RB
    Europace; 2020 Oct; 22(10):1463-1469. PubMed ID: 32830215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.